(Q43035645)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Isolated anti-HBc in chronic hepatitis C predicts a poor response to interferon treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Nicola Coppola

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Pietro Filippini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

C Scolastico

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A R Mogavero

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

M Stanzione

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F M Felaco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

F Piccinino

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

Journal of Medical Virology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

681-687

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease

5 December 2019

cites work

1 reference

"Occult" hepatitis B virus as source of infection in liver transplant recipients

21 January 2018

1 reference

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

21 January 2018

1 reference

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

21 January 2018

1 reference

Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance

21 January 2018

1 reference

The treatment of chronic viral hepatitis

21 January 2018

1 reference

Response of patients with dual hepatitis B virus and C virus infection to interferon therapy

21 January 2018

1 reference

Predictors of sustained response to alpha interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen

21 January 2018

1 reference

Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen

21 January 2018

1 reference

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients

21 January 2018

1 reference

Expression of interferon receptor genes in the liver as a predictor of interferon response in patients with chronic hepatitis C.

21 January 2018

1 reference

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

21 January 2018

1 reference

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

Fibrosis in patients with chronic hepatitis C: detection and significance

21 January 2018

1 reference

Randomised, double-blind, placebo-controlled trial of interferon alpha-2b with and without ribavirin for chronic hepatitis C. The Swedish Study Group

21 January 2018

1 reference

Therapy of hepatitis C: alpha interferon and ribavirin

21 January 2018

1 reference

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

21 January 2018

1 reference

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

21 January 2018

1 reference

HCV genotype and "silent" HBV coinfection: two main risk factors for a more severe liver disease

21 January 2018

1 reference

Identification of hepatitis B virus integration in hepatitis C virus-infected hepatocellular carcinoma tissues

21 January 2018

1 reference

Coinfection with hepatitis B and C or B, C and delta viruses results in severe chronic liver disease and responds poorly to interferon-alpha treatment.

21 January 2018

1 reference

Immunohistochemical analysis of hepatic interferon alpha-beta receptor level: relationship between receptor expression and response to interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group

21 January 2018

1 reference

A proposed system for the nomenclature of hepatitis C viral genotypes

21 January 2018

1 reference

Interferon for non-A, non-B chronic hepatitis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JMV.2090

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11745931%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference